Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novan Inc
(NQ:
NOVN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novan Inc
< Previous
1
2
3
4
5
Next >
Earnings Scheduled For March 30, 2023
March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
Via
Benzinga
Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
March 30, 2023
From
Novan, Inc.
Via
GlobeNewswire
Earnings Outlook For Novan
March 29, 2023
Via
Benzinga
Novan to Report Full Year 2022 Financial Results on March 30, 2023
March 23, 2023
From
Novan, Inc.
Via
GlobeNewswire
Looking Into Novan's Return On Capital Employed
December 23, 2022
Via
Benzinga
Novan Announces Closing of $6.0 Million Registered Direct Offering
March 16, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 14, 2023
Presentation with live webcast today, March 14th at 10:40 AM ET
From
Novan, Inc.
Via
GlobeNewswire
Novan Announces $6.0 Million Registered Direct Offering
March 14, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan Moves Forward with Unified Corporate Branding
March 08, 2023
From
Novan, Inc.
Via
GlobeNewswire
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
March 07, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
January 18, 2023
Live video webcast on Thursday, January 19th at 12:00 PM ET
From
Novan, Inc.
Via
GlobeNewswire
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
January 11, 2023
Via
ACCESSWIRE
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
January 06, 2023
From
Novan, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 21, 2022
Via
Benzinga
EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan
December 21, 2022
From
Novan, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 05, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 02, 2022
Via
Benzinga
EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement
December 02, 2022
From
Novan, Inc.
Via
GlobeNewswire
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
December 01, 2022
From
Novan, Inc.
Via
GlobeNewswire
Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From
Novan, Inc.
Via
GlobeNewswire
Novan to Report Third Quarter 2022 Financial Results on November 14, 2022
November 07, 2022
From
Novan, Inc.
Via
GlobeNewswire
EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference®
October 21, 2022
Research shows PAD (Polyaphron Dispersion) Technology™ leads to more efficient delivery of Calcipotriene (CAL) and Betamethasone Dipropionate (BDP) than CAL/BDP topical suspension
From
Novan, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference®
October 21, 2022
Data collected shows importance of treatment formulation characteristics and speed of improvement in psoriasis symptoms to patient treatment adherence
From
Novan, Inc.
Via
GlobeNewswire
Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference®
October 14, 2022
From
Novan, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
October 10, 2022
Gainers
Via
Benzinga
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
October 11, 2022
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...
Via
Benzinga
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
October 10, 2022
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 05, 2022
Wednesday saw 127 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.